Pheniramine, Phenylephrine Combo Excluded From Cough/Cold Monograph
This article was originally published in The Tan Sheet
Executive Summary
The combination of .2% pheniramine maleate and .5% phenylephrine hydrochloride for nasal decongestion associated with colds, sinusitis or allergic rhinitis was excluded from the OTC cough/cold combinations final monograph based on a lack of supporting data, according to FDA
You may also be interested in...
FDA Warns Matrixx On Combination Supplement/Drug Products
Matrixx Initiatives’ troubled history with FDA continues with a warning two of its products are unapproved new drugs because they combine supplements with OTC drugs.
FDA Warns Matrixx On Combination Supplement/Drug Products
Matrixx Initiatives’ troubled history with FDA continues with a warning two of its products are unapproved new drugs because they combine supplements with OTC drugs.
FDA Warns Matrixx On Combination Supplement/Drug Products
Matrixx Initiatives’ troubled history with FDA continues with a warning two of its products are unapproved new drugs because they combine supplements with OTC drugs.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: